Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. - Wikidata - wikimedia - TriplyDB

Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.

Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.

http://www.wikidata.org/entity/Q42981496

about

Gammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodents Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis Hepatitis C virus: epidemiology and genotypes in the north east of England.The clinical virology of hepatitis C virus Viruses as co-factors for the initiation or exacerbation of lung fibrosis Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab.Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.Nonhepatic manifestations and combined diseases in HCV infection.Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C.Recent advances in the aetiology of cryptogenic fibrosing alveolitis.Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis.Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection The epidemiology of interstitial lung disease and its association with lung cancer.Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection.Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis Determinants of initiation and progression of idiopathic pulmonary fibrosis.Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibody.The complex interrelationships between chronic lung and liver disease: a review.Relationship between hepatitis C virus infection and pulmonary disorders: potential mechanisms of interaction.Idiopathic pulmonary fibrosis-an epidemiological and pathological review.Viral infection and aging as cofactors for the development of pulmonary fibrosis.Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.Studying human respiratory disease in animals--role of induced and naturally occurring models.Advances in the treatment of idiopathic pulmonary fibrosis.Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation Systemic abnormalities in liver disease.Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection?Idiopathic pulmonary fibrosis and hepatitis C virus infection.Case-control study of medical history and idiopathic pulmonary fibrosis in Japan.Usefulness of the serum KL-6 assay in patients with hepatitis C virus.Inflammatory myopathy and hepatitis C virus infection.Sicca syndrome associated with hepatitis C virus infection.Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection.

P2860

Q26829291-93EFB06B-1CDB-4AA9-BF04-208520AA61B6 Q27469497-7F2AF7AA-9E64-42D7-9335-9E60A1531CFD Q27473017-80EB56DB-355F-4DE0-AAA4-5C3EFE26892F Q27481239-12997523-1C5A-42F9-86CD-9BD2D54D769F Q27487313-F31A302F-1329-4C9A-A730-E9EF5D7B3DDC Q28081676-A9B886CE-61AD-48F3-B56D-CB88E56FD0D0 Q28308246-38CC5808-99D3-417C-A13E-3CAEAECC9A39 Q33364746-EDC304CC-008D-4E8C-A06F-1CE88605A5BF Q33378075-A3EE6F52-BEE0-4BD5-8B07-963F63B264F1 Q33498313-15F2C934-6FED-4098-B017-E114992BCCB0 Q33775924-517CB20E-3298-4CD9-895D-80C7AFE853BF Q33901227-C688071B-89B6-41E9-B871-110A752450B7 Q34105545-F7AD01C8-CDC7-4E57-9A56-5D35309BC02D Q34998351-7D0DF8D6-2EC7-4F96-BCA4-ABB114F7C289 Q35027515-078D4E3B-44F1-4CFE-A65B-1BE09628B450 Q35731058-F9B2B5BA-A4F8-4FA7-9922-E9924F6FA493 Q35875981-50A39315-EBC6-41AF-A046-70ACB981FD97 Q36496266-E79C6101-6104-42F3-81EC-30C4B8F13D04 Q37002839-C4E1461E-97E4-4AA9-8F68-114F7E893D0D Q37263917-9CC74C13-BC7D-4697-B21E-623E6B8FCAB3 Q37362701-7E60BB80-B13C-43BB-A227-56B3F1874EED Q37594222-A2CD742D-C440-45BB-BA62-B9A41643EEF5 Q37660988-DAA37E7F-9ECA-4BFD-A6E4-192737F080C7 Q37729353-DA93CAD3-D64D-4126-9007-B50BBA75D8DD Q37755272-AFB3BE90-F63A-4E3D-A0C3-E6D93A752D66 Q37788591-FAACFB84-AB00-410D-8B63-0F4D775D8D26 Q37815487-9ED26215-81BE-4235-A950-17184B6D9103 Q38059610-AAC3D72B-6B8E-45E2-B9A3-84F94D50B1FD Q38607416-C3C597DC-0D97-4D96-8508-29EABCAF8133 Q38656594-CE5967C7-46F1-497E-AB04-E474B3400404 Q38914780-C123BFE7-F806-469E-9147-508197C52ED6 Q41713855-AA60C017-8902-404B-AB86-7ECB30737D1C Q42623529-406F5741-3376-45E5-9869-CD96F080F226 Q42774333-7E4A10DD-62AB-4B0A-9DCB-E11A6DC54BCD Q43035239-29059F8F-236C-4C3C-A68E-951A46716381 Q44906294-6B6FDFB0-C8D8-4C3E-BA17-3DD27EFB7B85 Q45435671-9244CE2E-6E8A-4DED-BC9C-C780B0EAB334 Q45754843-305B7773-1064-492C-94EC-B044BB6C9A93 Q45770092-27F5930E-C53F-45EE-AEBE-3B804870FC37 Q45770348-40BEDE1B-09D6-4FDD-83AD-18382246F4BA

P2860

Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.

http://www.wikidata.org/entity/Q42981496

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.

@en

Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.

@nl

type

label

Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.

@en

Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.

@nl

prefLabel

Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.

@en

Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.

@nl

P1433

Q42981496-3724C68D-BF57-4915-84CC-16E56904FE1D

P1476

Q42981496-43D8F76E-96BF-45EC-874A-7A3B25F01507

P2093

Q42981496-243F2B29-06D8-4BC2-A68D-8249C1430176

Q42981496-37177D21-708D-4B58-B175-8DCF66F7EC45

Q42981496-750C15E5-4843-4C23-BB54-9FF543C938B8

Q42981496-C5050A1F-7610-426F-8FDD-D3F5EBA6AC9D

Q42981496-C7AB1B85-C366-4327-BEC9-D4C467193313

Q42981496-DA39B39C-A453-4E67-9C7E-0801CF3E8120

Q42981496-DCD9523C-7F99-4C08-B88D-538EE9360F55

Q42981496-EA203F47-A2BC-4317-A5AE-4A305741C206

Q42981496-F88F915F-FD83-4D35-A6D9-2F45692E5991

P304

Q42981496-1337A35C-AFB3-44B1-BF0B-8C4B62379D55

P31

Q42981496-D439DA3B-9CC8-4616-89AD-524F52342553

P356

Q42981496-6E306671-02EA-4935-8842-48C2B125F722

P433

Q42981496-414EDC23-71D1-462D-9CDD-FA37BE1872C5

P478

Q42981496-3D59619A-309B-44FB-A91D-B45A44627656

P577

Q42981496-35DB52A2-132C-40AF-9074-34EF7AB4F464

P698

Q42981496-BB8B061B-7B4D-4CA4-9E0B-EBC9EBCD1FA2

P921

Q42981496-006E474D-63A1-47CD-BA12-E4F853C2A726

Q42981496-BAB0A227-7B21-4D48-A110-B2CEBA243C23

P356

P1433

The American Review of Respiratory Disease

P1476

Idiopathic pulmonary fibrosis ...... tibodies to hepatitis C virus.

@en

P2093

Hirai K

http://www.w3.org/2001/XMLSchema#string

Horiuchi T

http://www.w3.org/2001/XMLSchema#string

Ito K

http://www.w3.org/2001/XMLSchema#string

Miyamoto T

http://www.w3.org/2001/XMLSchema#string

Ohta K

http://www.w3.org/2001/XMLSchema#string

Suzuki N

http://www.w3.org/2001/XMLSchema#string

Ueda T

http://www.w3.org/2001/XMLSchema#string

Watanabe J

http://www.w3.org/2001/XMLSchema#string

Yamaguchi M

http://www.w3.org/2001/XMLSchema#string

P304

266-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM/146.1.266

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

1992-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1320820

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis